Quarterly report · Q2
6338.TEDINET S100TEV8
Period2023-10-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥16.4bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥825m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.6bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥862m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥862m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥591m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥591m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥17.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥18.0bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥14.0bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.9bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥9.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥162m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥432m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥78m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥114m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥70m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥59m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥217.39 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.51 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥349.42 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.26 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.33 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.4% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01715-000Electronic Equipmentreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥10.0bn |
| jpcrp040300-q2r_E01715-000Electronic Equipmentreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E01715-000Medical Equipmentreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥49m |
| jpcrp040300-q2r_E01715-000Medical Equipmentreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥55m |
| jpcrp040300-q2r_E01715-000Taxtile Equipmentreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥79m |
| jpcrp040300-q2r_E01715-000Taxtile Equipmentreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥34m |
| jpcrp040300-q2r_E01715-000Electronic Equipmentreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥6.0bn |
| jpcrp040300-q2r_E01715-000Electronic Equipmentreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥874m |
| jpcrp040300-q2r_E01715-000Medical Equipmentreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥185m |
| jpcrp040300-q2r_E01715-000Medical Equipmentreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥5m |
| jpcrp040300-q2r_E01715-000Taxtile Equipmentreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥54m |
| jpcrp040300-q2r_E01715-000Taxtile Equipmentreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥45m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 457
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1YTDDuration | -69588000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 77528000 | JPY |
| Increase in short term loans payable fin cf | Prior1YTDDuration | 300000000 | JPY |
| Increase in short term loans payable fin cf | CurrentYTDDuration | 2000000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Decrease in short term loans payable fin cf | CurrentYTDDuration | -210000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -72498000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -39998000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -4039000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -8540000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -390000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -154000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -164161000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -218556000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 58911000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 1522750000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -4041000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 373000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -446829000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 1438237000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 3056406000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 4437815000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2609576000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5876052000 | JPY |
| Employees salaries and allowances sga | Prior1YTDDuration | 143681000 | JPY |
| Employees salaries and allowances sga | CurrentYTDDuration | 149998000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 27787000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 32644000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 21907000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 81053000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01715-000ElectronicEquipmentReportableSegmentsMember | 6028818000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01715-000TaxtileEquipmentReportableSegmentsMember | 54052000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01715-000MedicalEquipmentReportableSegmentsMember | 184668000 | JPY |
| Net sales | Prior1YTDDuration | 6267539000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01715-000ElectronicEquipmentReportableSegmentsMember | 874381000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01715-000TaxtileEquipmentReportableSegmentsMember | -44786000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01715-000MedicalEquipmentReportableSegmentsMember | -4519000 | JPY |
| Operating income | Prior1YTDDuration | 825075000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01715-000ElectronicEquipmentReportableSegmentsMember | 10042441000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01715-000TaxtileEquipmentReportableSegmentsMember | 78939000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01715-000MedicalEquipmentReportableSegmentsMember | 49111000 | JPY |
| Net sales | CurrentYTDDuration | 10170491000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01715-000ElectronicEquipmentReportableSegmentsMember | 1904930000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01715-000TaxtileEquipmentReportableSegmentsMember | -34036000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01715-000MedicalEquipmentReportableSegmentsMember | -55495000 | JPY |
| Operating income | CurrentYTDDuration | 1815398000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-05-14 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |